Biotech company Biogen (NASDAQ:BIIB) in Q1 CY2025, with sales up 6.1% year on year to $2.43 billion. Its non-GAAP profit of ...

We recently published a list of 15 Small-Cap Healthcare Stocks Hedge Funds Are Buying. In this article, we are going to take ...

Visit a quote page and your recently viewed tickers will be displayed here. Mr. Hawkins is the retired Chairman and CEO of Medtronic and has had a long and distinguished career in the Medical Devices ...

Biogen Inc (NASDAQ:BIIB) reported a strong start to the year with a significant increase in revenue from new product launches, contributing to 45% of product revenue. The company received FDA Fast ...

Biogen Inc (NASDAQ:BIIB) reported a strong start to the year with a significant increase in revenue from new product launches, contributing to 45% of product revenue. The company received FDA Fast ...

Biogen’s CEO Chris Vibacher said ‘a new Biogen’ is emerging following the end of its multiple sclerosis treatments heyday.

Good morning. My name is Melinda, and I'll be your conference operator today. At this time, I'd like to welcome everyone to the Biogen First Quarter 2025 Earnings Call and Business Update. All ...

Investors in Biogen Inc (Symbol: BIIB) saw new options begin trading today, for the June 13th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the BIIB options ...

Biotech company Biogen (NASDAQ:BIIB) reported Q1 CY2025 results exceeding the market’s revenue expectations , with sales up 6.1% year on year to $2.43 billion. Its non-GAAP profit of $3.02 per ...

Biotech company Biogen (NASDAQ:BIIB) reported Q1 CY2025 results exceeding the market’s revenue expectations , with sales up 6.1% year on year to $2.43 billion. Its non-GAAP profit of $3.02 per share ...